Register of Ohio

Filings for Rule Number 4729:8-3-04

Title Frequency requirements for submitting drug database information.
Agency State Board of Pharmacy
Division Drug Database
Contact Cameron McNamee
Phone 614-466-7322

Actions

Public Notice RSFA Analysis Rule Appendices Hearing Summary Reports CSI Business Impact Analysis CSI Recommendation CSI Agency Memorandum
   of Response		 Documents
Title File Date Action Type Class Hearing Eff Date Exp Date FYR Public Notice Icon RSFA Analysis Icon Rule doc Icon Appendices Icon Hearing Summary Report Icon CSI Business Impact Analysis Icon CSI Recommendation Icon Memorandum of Response Icon Documents
No Current Actions
Public Notice RSFA Analysis Rule Appendices Hearing Summary Reports CSI Business Impact Analysis CSI Recommendation CSI Agency Memorandum
   of Response		 Documents
Title File Date Action Type Class Hearing Eff Date Exp Date FYR Public Notice Icon RSFA Analysis Icon Rule doc Icon Appendices Icon Hearing Summary Report Icon CSI Business Impact Analysis Icon CSI Recommendation Icon Memorandum of Response Icon Documents
Frequency requirements for submitting drug database information. 06/12/2025 Final File Amendment 119.03 08/01/2025 Y View Rule Document View Hearing Summary Report Document View CSI Business Impact Analysis Document View CSI Recommendation Document View CSI Agency Memorandum of Response Document
Frequency requirements for submitting drug database information. 06/12/2025 Withdraw Final Amendment 119.03 Y View Rule Document View CSI Business Impact Analysis Document View CSI Recommendation Document View CSI Agency Memorandum of Response Document
Frequency requirements for submitting drug database information. 06/12/2025 Final File Amendment 119.03 07/01/2025 Y View Rule Document View CSI Business Impact Analysis Document View CSI Recommendation Document View CSI Agency Memorandum of Response Document
Frequency requirements for submitting drug database information. 04/01/2025 Original File Amendment 119.03 05/06/2025 Y View Public Notice Document View RSFA Analysis Document View Rule Document View CSI Business Impact Analysis Document View CSI Recommendation Document View CSI Agency Memorandum of Response Document
Frequency requirements for submitting drug database information. 02/19/2019 Final File New 119.03 03/15/2019 N View Rule Document View CSI Business Impact Analysis Document View CSI Recommendation Document View CSI Agency Memorandum of Response Document
Frequency requirements for submitting drug database information. 01/16/2019 Withdraw Final New 119.03 N View Rule Document View CSI Business Impact Analysis Document View CSI Recommendation Document View CSI Agency Memorandum of Response Document
Frequency requirements for submitting drug database information. 01/14/2019 Final File New 119.03 02/01/2019 N View Rule Document View CSI Business Impact Analysis Document View CSI Recommendation Document View CSI Agency Memorandum of Response Document
Frequency requirements for submitting drug database information. 11/26/2018 Revise New 119.03 N View RSFA Analysis Document View Rule Document View CSI Business Impact Analysis Document View CSI Recommendation Document View CSI Agency Memorandum of Response Document
Frequency requirements for submitting drug database information. 11/08/2018 Original File New 119.03 12/13/2018 N View Public Notice Document View RSFA Analysis Document View Rule Document View CSI Business Impact Analysis Document View CSI Recommendation Document View CSI Agency Memorandum of Response Document